Last updated 2026-07-20
- Raised $2M grant, Jul 2024
- Raised Undisclosed Round led by G.O Innovation, Dec 2017
Total raised
$2.0M
Last: Grant 2024-08
Stage
Seed
Founded
2015
Headcount
15
HQ
Yokne'am Illit, Israel
Sector
Health Tech & Life Sciences
About
Cytora is an Israeli biopharmaceutical company at the forefront of stem cell therapy. It is a clinical-stage company developing a new class of "Off the Shelf" medicines based on a novel and transformative patented platform technology derived from unique human Oral Mucosa Stem Cells (hOMSC). The company's technology is based on a unique patented platform utilizing a highly potent stem cell population found in human adult oral mucosa. The primary application for their therapies is the treatment of non-closing wounds, such as diabetic foot ulcers, and neurodegenerative diseases like Parkinson's disease, multiple system atrophy (MSA), and Alzheimer's disease.
Funding history · 2 rounds · $2.0M total
2024-07
Grant
$2.0M
2017-12
Undisclosed Round
Undisclosed
★ G.O Innovation★ Net Capital Ventures
Headcount over time
From 13 (2023-08) to 14 (2025-12) · +1 (+8%) · 10 points · source: Finder history + radar grounding
Q&A
- What is Cytora's primary mission?
- Cytora's mission is to establish off-the-shelf (allogeneic) Stem Cell medicines, derived from human oral mucosa stem cells (hOMSC), as a standard treatment for severe diseases such as Parkinson’s, Multiple System Atrophy (MSA), Alzheimer’s Dementia, and non-healing diabetic wounds.
- When was Cytora founded?
- Cytora was founded in April 2015.
- What is Cytora's total funding to date?
- Cytora has raised a total of $2,000,000.
- When was Cytora's most recent funding round and who participated?
- Cytora's most recent funding round was a Grant in August 2024, with participation from Israel Innovation Authority.
- Who are the co-founders of Cytora?
- The co-founders of Cytora are Jacob Zankel, who also serves as Co-founder & CEO, and Prof. Sandu Pitaru, who is Co-founder, CTO & VPR.
- What sector does Cytora operate in?
- Cytora operates in the Health Tech & Life Sciences sector, specifically focusing on Pharma & Medical Biotechnology and Drugs Discovery & Development.
- Is Cytora a portfolio company of an incubator?
- Yes, Cytora is a portfolio company of Galil Ofek Innovations, an incubator focused on biomedical technologies.
Team · 2
Prof. Sandu Pitaru
Founder · Co-founder, CSO, VP R&D & Clinical Affairs
Jacob Zankel
Founder · Co-founder & COO
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 Patents
Tags
alzheimers-diseasemedical-technologiestherapeuticspharma-companiesdiabetesulcerscell-therapystem-cellsregenerative-medicinebiotechnologyparkinson
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | cytorastem.com/ |
|---|---|
| linkedin.com/company/77067876 |
Identifiers & details
| Legal name | CYTORA LTD |
|---|---|
| Founded | 2015-4 |
| Employees (exact) | 15 |
Radar intelligence
Patents
| EPO | 3 |
|---|
GitHub
| Top repos | pycon-nlp-in-10-lines, clickbait-workshop, gopher-tweets-function, goroutines-channels-talks, datasketch |
|---|
Web history (Wayback)
| Domain | cytorastem.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 515246775 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2015-04-26 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 1 |
| Registry events | 2 — charge (1), people (1) |
| Registered address | התנופה 3 יקנעם עילית |
Recent registry events
| Date | Event |
|---|---|
| 2026-01-21 | רישום שעבוד |
| 2025-09-17 | עדכון בעלי תפקידים |